pars planitis: Form of granulomatous uveitis occurring in the region of the pars plana. This disorder is a common condition with no detectable focal pathology. It causes fibrovascular proliferation at the inferior ora serrata.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1269 |
4. Check minimum number of eventsNone |
1269 |
5. Include endpointsNone |
1269 |
6. Filter based on genotype QC (FinnGen only) |
1120 |
Control definitions (FinnGen only)
- Control exclude
- H7_CHOROIDRETINA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Chorioretinal inflammation
based on the number of shared cases.
Similar with more cases:
- Disorders of choroid and retina
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7447 | 4043 | 3349 |
| Only index persons | 6715 | 3705 | 3010 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.12 | 0.09 |
| Only index persons | 0.13 | 0.14 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 44.36 | 45.40 | 43.18 |
| Only index persons | 43.01 | 43.90 | 41.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1120 | 666 | 454 |
| Unadjusted period prevalence (%) | 0.22 | 0.24 | 0.21 |
| Median age at first event (years) | 47.31 | 44.48 | 51.46 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1153
- Matched controls
- 11530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H30.2
ICD-10 Finland
Posterior cyclitis
+∞
307.7
446
*
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
26.0
307.7
333
177
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
20.6
307.7
308
200
H20.1
ICD-10 Finland
Chronic iridocyclitis
129.4
307.7
237
23
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
197.9
307.7
169
10
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
+∞
273.1
251
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
11.8
251.4
292
322
CKC12
NOMESCO Finland
Photocoagulation of retina
98.2
221.0
115
13
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.4
206.7
285
389
XCK10
NOMESCO Finland
Photography of fundus of eye
8.9
187.1
268
381
WX140
NOMESCO Finland
Parabulbar anesthesy
21.7
182.6
140
73
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
73.0
173.4
94
14
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.8
172.3
331
644
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.5
158.7
414
1062
S01ED51
ATC
timolol, combinations; ophthalmic
8.5
154.8
223
316
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
58.0
143.6
81
15
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
67.7
138.5
76
12
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
+∞
135.1
127
*
H26.2
ICD-10 Finland
Complicated cataract
30.9
118.0
78
27
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
+∞
116.7
110
*
S01ED01
ATC
timolol; ophthalmic
12.3
115.9
120
108
S01EC01
ATC
acetazolamide; systemic
16.9
111.5
95
61
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
49.9
98.0
57
12
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
26.3
96.0
67
27
CJB10
NOMESCO Finland
Laser discission of secondary cataract
6.3
94.7
175
318
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
24.0
94.2
68
30
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
93.0
88
*
S01BA04
ATC
prednisolone; ophthalmic
11.9
92.9
97
88
H02AB06
ATC
prednisolone; systemic
3.6
92.7
760
4051
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
174.3
92.7
96
6
L04AX03
ATC
methotrexate; systemic
4.8
92.0
242
602
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.5
89.1
260
701
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.4
87.1
466
1899
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
14.9
85.9
78
56
H43.1
ICD-10 Finland
Vitreous haemorrhage
18.5
84.0
68
39
H33.0
ICD-10 Finland
Retinal detachment with retinal break
868.7
83.6
81
*
S01EA05
ATC
brimonidine; ophthalmic
11.0
76.4
84
82
XCK00
NOMESCO Finland
Perimetry
6.3
75.5
137
243
S01BA01
ATC
dexamethasone; ophthalmic
7.6
74.8
111
159
A10AB01
ATC
insulin (human); parenteral
10.7
74.2
83
83
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
73.7
70
*
H26.4
ICD-10 Finland
After-cataract
4.9
73.1
180
420
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
16.9
72.3
61
38
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
15.4
71.2
63
43
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.0
70.5
495
2307
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
91.7
69.9
77
9
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
16.8
69.7
59
37
A10AA01, ,
ATC
12.6
68.2
68
57
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.9
63.8
220
660
XCD20
NOMESCO Finland
Photoangiography of eye
93.1
63.7
70
8
CKD40
NOMESCO Finland
Endophotocoagulation of retina
+∞
63.1
60
*
S01BC03
ATC
diclofenac; ophthalmic
9.9
61.3
72
77
36504
ICD-8 Finland
Choroiditis, Retinis, Retino-chorioiditis
+∞
61.0
58
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
13.9
60.8
57
43
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
7.3
58.8
90
133
H04AA01
ATC
glucagon; nasal, parenteral
13.0
58.5
57
46
A10AA02, ,
ATC
10.0
58.2
68
72
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
597.0
58.2
57
*
H26.3
ICD-10 Finland
Drug-induced cataract
25.0
57.8
41
17
H33.3
ICD-10 Finland
Retinal breaks without detachment
586.0
57.1
56
*
XCH00
NOMESCO Finland
Eye pressure measurement
6.1
54.4
99
175
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
54.2
603
3435
A10AB04
ATC
insulin lispro; parenteral
8.2
54.1
74
96
114
Kela drug reimbursment
Glaucoma
4.1
50.2
150
403
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
49.6
655
3986
H3603, E103,
ICD-10 Finland
+∞
49.3
47
*
CKA10
NOMESCO Finland
Biopsy of vitreous body
177.7
49.3
51
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
14.1
48.7
45
33
S01BA07
ATC
fluorometholone; ophthalmic
10.6
47.8
53
52
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
12.5
47.3
47
39
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
465.4
45.6
45
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
159.5
44.1
46
*
H3600, E103,
ICD-10 Finland
+∞
44.0
42
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.0
43.6
80
142
S01FA04
ATC
cyclopentolate; ophthalmic
11.4
42.6
45
41
CS494
NOMESCO Finland
Other visual field testing
6.7
42.2
69
109
H3601, E103,
ICD-10 Finland
+∞
41.9
40
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
11.4
41.7
44
40
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
40.9
39
*
H35.36
ICD-10 Finland
Macular cyst
400.6
39.3
39
*
S01EC04
ATC
brinzolamide; ophthalmic
5.4
37.7
77
151
H02AB07
ATC
prednisone; oral
2.8
37.2
220
896
CKC10
NOMESCO Finland
Local photocoagulation of retina
196.3
37.0
38
*
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
103.5
36.9
40
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
8.7
36.7
47
56
A10AC01
ATC
insulin (human); parenteral
3.8
36.2
118
335
H40.0
ICD-10 Finland
Glaucoma suspect
3.5
36.2
134
415
S01FA02
ATC
scopolamine; ophthalmic
13.4
35.8
34
26
T89
ICPC
Diabetes insulin dependent
5.3
35.7
74
147
H32.0
ICD-10 Finland
Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
+∞
35.6
34
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
12.0
35.3
36
31
L04AB04
ATC
adalimumab; parenteral
6.3
35.3
61
102
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
80.8
35.0
39
5
H25.1
ICD-10 Finland
Senile nuclear cataract
2.4
34.7
319
1600
Z3229
NOMESCO Finland
Other healthcare associate professional
3.4
34.6
135
432
A10AB05
ATC
insulin aspart; parenteral
3.7
34.2
117
343
S01EE01
ATC
latanoprost; ophthalmic
4.1
34.1
100
263
H36.01
ICD-10 Finland
Diabetic maculopathy
180.3
33.9
35
*
A10AD01
ATC
insulin (human); parenteral
10.0
33.1
38
39
A10AE05
ATC
insulin detemir; parenteral
4.3
33.0
89
220
H35.8
ICD-10 Finland
Other specified retinal disorders
175.0
32.9
34
*
3632A
ICD-9 Finland
Chorioretinal inflammations and scars and other disorders of choroid, Other and unspecified forms of chorioretinitis and retinochoroiditis
+∞
32.4
31
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.9
32.1
50
75
L04AX01
ATC
azathioprine; systemic
4.4
32.0
84
203
H34.8
ICD-10 Finland
Other retinal vascular occlusions
87.6
30.9
34
*
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
164.4
30.8
32
*
S01EC54
ATC
brinzolamide, combinations; ophthalmic
10.6
30.8
34
33
L04AA06
ATC
mycophenolic acid; systemic
6.7
30.4
49
76
36509
ICD-8 Finland
Choroiditis, Unspecified
+∞
30.3
29
*
H25.8
ICD-10 Finland
Other senile cataract
3.0
30.2
143
513
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
310.2
29.9
30
*
H35.9
ICD-10 Finland
Retinal disorder, unspecified
67.8
29.0
33
5
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
82.3
28.9
32
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
288.2
27.9
28
*
ZXA10
NOMESCO Finland
Bilateral
2.4
27.7
231
1099
CKD20
NOMESCO Finland
Removal of vitreous body substitute
+∞
27.2
26
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.9
27.1
144
549
H46
ICD-10 Finland
Optic neuritis
9.2
26.9
33
37
CKC15
NOMESCO Finland
Panretinal photocoagulation
77.1
26.9
30
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
26.8
93
275
S01EA03
ATC
apraclonidine; ophthalmic
26.5
26.3
36
14
36501
ICD-8 Finland
Choroiditis, Centralis
+∞
26.1
25
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.8
25.8
140
540
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
95.6
25.8
28
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
51.3
25.3
30
6
H35.7
ICD-10 Finland
Separation of retinal layers
+∞
25.1
24
*
CKD15
NOMESCO Finland
Injection of vitreous substitute
+∞
25.1
24
*
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
20.6
24.4
36
18
A02BC02
ATC
pantoprazole; systemic
2.0
24.3
828
6453
TAB00
NOMESCO Finland
Lumbar puncture
3.5
24.2
88
268
CK9G4
NOMESCO Finland
Iridocyanine green angiography (ICGA) of choroid and retina
+∞
24.0
23
*
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
24.0
114
408
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
88.7
23.7
26
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
23.4
416
2615
S01BC05
ATC
ketorolac; ophthalmic
4.2
22.7
61
150
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
53.1
22.2
26
5
H3601, E113,
ICD-10 Finland
+∞
21.9
21
*
36508
ICD-8 Finland
Choroiditis, Alia definita
+∞
21.9
21
*
A10AE04
ATC
insulin glargine; parenteral
2.7
21.8
124
489
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
21.4
119
463
R4180
NOMESCO Finland
Podiatric therapy
7.7
21.3
30
40
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
78.3
20.7
23
*
SPAT1262
SPAT
Handing over of treatment supplies
2.2
20.7
211
1080
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
213.7
20.6
21
*
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
8.4
20.6
27
33
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
20.4
58
149
L01BA01
ATC
methotrexate; systemic
3.9
20.0
60
160
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
4.1
20.0
55
138
H04.10
ICD-10 Finland
Dry eye syndrome
2.3
19.7
168
799
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
20.5
19.1
28
14
S01EE03
ATC
bimatoprost; ophthalmic
5.2
18.9
39
77
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.6
18.9
63
181
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
18.9
102
391
H3603, E113,
ICD-10 Finland
+∞
18.8
18
*
36503
ICD-8 Finland
Choroiditis, Juxta-papillaris
+∞
18.8
18
*
H20.8
ICD-10 Finland
Other iridocyclitis
17.5
18.8
29
17
M45
ICD-10 Finland
Ankylosing spondylitis
4.5
18.6
46
106
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
33.5
18.0
23
7
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
+∞
17.8
17
*
H31.0
ICD-10 Finland
Chorioretinal scars
+∞
17.8
17
*
B58.0
ICD-10 Finland
Toxoplasma oculopathy
+∞
17.8
17
*
H53.4
ICD-10 Finland
Visual field defects
4.9
17.6
39
82
S01EE05
ATC
tafluprost; ophthalmic
3.7
17.4
56
157
OAB50, ,
SPAT
2.5
17.4
113
475
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
4.6
16.7
40
90
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
28.0
16.5
22
8
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.8
16.4
50
135
109
Kela drug reimbursment
Multiple sclerosis
6.4
16.3
27
43
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
4.3
16.3
42
100
A10AA03, ,
ATC
17.0
16.1
25
15
WX142
NOMESCO Finland
Sub-tenon anesthesy
21.3
16.0
23
11
A10AE06
ATC
insulin degludec; parenteral
3.6
16.0
53
152
H26.02
ICD-10 Finland
Presenil cataract
4.0
15.9
45
115
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.5
15.9
100
414
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
15.9
15.7
25
16
3630A
ICD-9 Finland
Chorioretinal inflammations and scars and other disorders of choroid, Focal chorioretinitis and focal retinochoroiditis
+∞
15.7
15
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
19.5
15.6
23
12
H35.37
ICD-10 Finland
Macular holes
162.1
15.5
16
*
J01FF01
ATC
clindamycin; systemic
1.8
15.5
327
2117
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.4
15.3
39
92
132
Kela drug reimbursment
Sarcoidosis
11.4
15.3
28
25
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
7.1
15.3
23
33
G35
ICD-10 Finland
Multiple sclerosis
4.9
15.0
33
69
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
4.4
14.8
37
86
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
14.6
167
886
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
+∞
14.6
14
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.2
14.0
55
176
TGC00
NOMESCO Finland
Bronchial lavation
3.6
13.9
45
127
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
6.3
13.8
23
37
H25.0
ICD-10 Finland
Senile incipient cataract
2.6
13.7
81
325
H35.6
ICD-10 Finland
Retinal haemorrhage
+∞
13.6
13
*
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
11.1
13.5
25
23
ZXA05
NOMESCO Finland
Left side
1.8
13.5
266
1679
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.2
13.5
26
26
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
13.3
125
616
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
12.9
110
520
SPAT1263
SPAT
Sampling
1.6
12.9
461
3389
H44.1
ICD-10 Finland
Other endophthalmitis
50.6
12.9
15
*
H35.4
ICD-10 Finland
Peripheral retinal degeneration
50.6
12.9
15
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
12.8
268
1718
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
3.0
12.7
56
192
L04AD01
ATC
ciclosporin; systemic
4.7
12.6
29
63
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
32.4
12.6
16
5
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
11.2
12.6
23
21
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
+∞
12.5
12
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
131.4
12.5
13
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
131.4
12.5
13
*
H43.3
ICD-10 Finland
Other vitreous opacities
5.1
12.5
26
52
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
12.4
77
316
WX002
NOMESCO Finland
Sedation and analgesia
1.8
12.4
211
1273
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
12.4
284
1866
H47.1
ICD-10 Finland
Papilloedema, unspecified
11.8
12.3
22
19
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.3
12.2
31
73
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.0
12.2
34
86
127
Kela drug reimbursment
Transplant complication
5.1
12.0
25
50
H16.0
ICD-10 Finland
Corneal ulcer
2.6
11.8
70
281
J05AB11
ATC
valaciclovir; oral
1.8
11.8
181
1057
S01EE04
ATC
travoprost; ophthalmic
4.7
11.7
27
59
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
11.7
51
174
H36.00
ICD-10 Finland
Diabetic background retinopathy
30.4
11.7
15
5
Z3231
NOMESCO Finland
Registered nurse
1.7
11.6
297
2002
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
19.1
11.6
17
9
S01FA01
ATC
atropine; ophthalmic
23.2
11.6
16
7
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
23.2
11.6
16
7
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.3
11.5
29
68
S01EC03
ATC
dorzolamide; ophthalmic
5.8
11.5
21
37
1302A
ICD-9 Finland
Toxoplasmosis, Chorioretinitis due to toxoplasmosis
+∞
11.5
11
*
36500
ICD-8 Finland
Choroiditis, Anterior
+∞
11.5
11
*
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
11.5
11
*
H3602, E103,
ICD-10 Finland
+∞
11.5
11
*
CHC05
NOMESCO Finland
Iridotomy
4.6
11.2
26
57
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
20.3
11.1
16
8
H33.5
ICD-10 Finland
Other retinal detachments
20.3
11.1
16
8
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.0
11.1
31
79
H02AB09
ATC
hydrocortisone; systemic
3.7
11.0
34
93
ZXE00
NOMESCO Finland
One hour or less
1.5
10.9
419
3106
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
10.8
322
2248
H57.1
ICD-10 Finland
Ocular pain
2.7
10.8
58
222
Z49.1
ICD-10 Finland
Extracorporeal dialysis
5.6
10.7
20
36
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
10.7
118
617
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.7
10.6
57
218
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
5.3
10.6
21
40
H34.2
ICD-10 Finland
Other retinal artery occlusions
111.0
10.4
11
*
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
111.0
10.4
11
*
CKC30
NOMESCO Finland
Cryopexy of detached retina
+∞
10.4
10
*
CKC60
NOMESCO Finland
Local buckling of sclera using implant
+∞
10.4
10
*
36502
ICD-8 Finland
Choroiditis, Disseminata
+∞
10.4
10
*
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
+∞
10.4
10
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
10.4
412
3064
ZXA00
NOMESCO Finland
Right side
1.6
10.4
276
1874
H20
ICD-10 Finland
Iridocyclitis
9.7
10.3
20
21
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
13.3
10.2
17
13
H40.9
ICD-10 Finland
Glaucoma, unspecified
3.9
10.2
29
75
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
10.1
92
448
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
4.7
10.0
23
50
D86
ICD-10 Finland
Sarcoidosis
40.4
10.0
12
*
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
5.2
9.9
20
39
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
4.4
9.8
24
55
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
9.8
89
432
TK800
NOMESCO Finland
Hemodialysis
3.8
9.8
29
77
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.5
9.7
32
92
ZX120
NOMESCO Finland
Intravenous
2.0
9.7
107
560
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.3
9.7
19
36
P01BA02
ATC
hydroxychloroquine; oral
2.1
9.6
95
477
M05BA04
ATC
alendronic acid; oral
2.1
9.5
93
465
WZC30
NOMESCO Finland
Teaching
1.7
9.5
181
1125
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.2
9.4
84
405
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
100.8
9.4
10
*
H33.2
ICD-10 Finland
Serous retinal detachment
+∞
9.4
9
*
H3600, E113,
ICD-10 Finland
+∞
9.4
9
*
H32.0*A18.5
ICD-10 Finland
Lupus chorioretinitis
+∞
9.4
9
*
36700
ICD-8 Finland
Inflammation of optic nerve and retina, Retinitis infectiosa
+∞
9.4
9
*
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
9.4
28
75
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
4.0
9.4
26
66
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
9.1
253
1729
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
9.0
123
690
F29
ICPC
Eye symptom/complaint other
1.9
9.0
123
690
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
37.0
9.0
11
*
L88
ICPC
Rheumatoid/seropositive arthritis
2.6
9.0
51
201
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
4.2
8.9
23
55
D86.3
ICD-10 Finland
Sarcoidosis of skin
24.2
8.9
12
5
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.9
405
3081
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.7
8.8
27
74
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.1
8.7
86
431
SPAT1301
SPAT
No procedures
1.5
8.7
319
2320
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
8.6
138
814
C03CA01
ATC
furosemide; systemic
1.5
8.6
279
1972
B37.7
ICD-10 Finland
Candidal sepsis
16.4
8.6
13
8
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
8.5
71
333
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.5
245
1685
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
8.5
292
2091
R50.9
ICD-10 Finland
Fever, unspecified
1.7
8.5
170
1069
H16.9
ICD-10 Finland
Keratitis, unspecified
3.6
8.4
27
76
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
90.7
8.4
9
*
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
90.7
8.4
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
8.4
67
309
J01MA12
ATC
levofloxacin; systemic
1.6
8.4
196
1283
H15.1
ICD-10 Finland
Episcleritis
3.8
8.4
25
67
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
+∞
8.3
8
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.9
8.3
38
134
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
7.1
8.3
19
27
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.5
8.2
49
198
UKC02
NOMESCO Finland
Cystoscopy
1.7
8.2
156
966
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.4
8.1
29
88
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
33.6
8.1
10
*
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
17.3
8.1
12
7
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
7.3
8.0
18
25
BEF00, ,
SPAT
7.3
8.0
18
25
S01EX03, ,
ATC
4.5
7.9
19
43
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
7.9
325
2411
L04AA01
ATC
[U] ciclosporin
4.7
7.9
18
39
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
7.8
7.9
17
22
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.8
239
1664
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.8
269
1925
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.7
417
3255
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
15.1
7.7
12
8
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.7
248
1746
H54.1
ICD-10 Finland
Severe visual impairment, binocular
45.3
7.7
9
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.4
7.7
19
44
H26.8
ICD-10 Finland
Other specified cataract
6.0
7.7
20
34
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
7.7
110
628
A12AA04
ATC
calcium carbonate; oral
4.1
7.6
20
49
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
7.5
75
378
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
7.5
69
337
S01AD03
ATC
aciclovir; ophthalmic
2.6
7.5
42
165
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
7.5
78
400
UJF92
NOMESCO Finland
Capsular endoscopy
3.2
7.4
29
93
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.4
446
3544
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
7.4
51
221
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
7.4
288
2110
H02AB04
ATC
methylprednisolone; systemic
1.7
7.3
151
955
CKC70
NOMESCO Finland
Circular buckling of sclera
+∞
7.3
7
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.9
7.3
85
454
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.2
364
2802
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
7.2
596
5000
171
Kela drug reimbursment
Degludekinsuliini
20.2
7.1
10
5
S01ED02
ATC
betaxolol; ophthalmic
6.6
7.1
17
26
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
7.1
60
284
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
7.1
136
845
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
7.0
109
637
SPAT1211
SPAT
Application of soft bandage
1.9
6.9
87
476
J05AB01
ATC
aciclovir; systemic
1.5
6.9
239
1705
Z94.0
ICD-10 Finland
Kidney transplant status
5.9
6.9
18
31
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.7
6.8
35
132
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
40.3
6.8
8
*
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
40.3
6.8
8
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
16.8
6.7
10
6
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
4.0
6.6
18
45
CHD99
NOMESCO Finland
Other filtering operation
12.3
6.6
11
9
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
12.3
6.6
11
9
137
Kela drug reimbursment
Uraemia requiring dialysis
6.9
6.5
15
22
177
Kela drug reimbursment
Insulin glargine 300 U / ml
3.7
6.5
20
55
H40
ICD-10 Finland
Glaucoma
6.2
6.5
16
26
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
70.2
6.4
7
*
S01BC01
ATC
indometacin; ophthalmic
70.2
6.4
7
*
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
7.4
6.4
14
19
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.4
784
6954
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
6.4
397
3155
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.6
6.3
15
23
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.3
634
5437
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.6
6.3
20
56
J01DB01
ATC
cefalexin; oral
1.5
6.3
910
8295
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
11.1
6.3
11
10
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
9.3
6.3
12
13
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
6.3
256
1886
CKD50
NOMESCO Finland
Endodiathermy of retina
+∞
6.3
6
*
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
+∞
6.3
6
*
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
+∞
6.3
6
*
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
+∞
6.3
6
*
H34.1
ICD-10 Finland
Central retinal artery occlusion
+∞
6.3
6
*
H44.4
ICD-10 Finland
Hypotony of eye
+∞
6.3
6
*
1LA05, ,
NOMESCO Finland
+∞
6.3
6
*
L04AA52
ATC
[U] ofatumumab; parenteral
+∞
6.3
6
*
F05
ICPC
Visual disturbance other
2.5
6.2
37
150
H54.7
ICD-10 Finland
Unspecified visual loss
7.1
6.2
14
20
ZX198
NOMESCO Finland
Other local administration
7.1
6.2
14
20
L04AD02
ATC
tacrolimus; systemic
5.1
6.2
18
36
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.3
6.2
46
207
A10AB06
ATC
insulin glulisine; parenteral
6.3
6.2
15
24
WX204
NOMESCO Finland
Axillary plexus blockaced
2.3
6.2
43
188
J01EA01
ATC
trimethoprim; systemic
1.5
6.2
255
1883
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.7
6.1
13
17
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.1
994
9240
SPAT1325
SPAT
Vaccination
1.4
6.1
308
2359
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
6.1
37
152
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.0
466
3828
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.0
495
4105
S01XA18
ATC
ciclosporin; ophthalmic
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
343
459
10.21
255.81
3.0
2.0
41.56
38.67
u/l
1.37
321
415
259
343
9.45
191.83
1.8
1.5
0.33
0.11
iu/ml
0.47
41
50
224
293
9.25
166.59
2.6
2.2
10.53
11.53
mg/l
0.85
219
267
120
123
10.77
106.04
2.3
2.5
54.03
38.68
iu/ml
—
20
10
122
141
9.56
98.59
1.1
1.2
—
—
—
0
0
254
708
4.32
82.87
2.6
2.5
12.90
20.41
au/ml
1.58
17
83
241
648
4.44
82.43
1.3
1.4
38.96
40.94
au/ml
0.06
11
52
72
59
12.95
73.33
2.4
2.4
251.15
244.04
e6/l
0.07
66
53
62
58
11.24
57.88
2.2
2.2
436.41
681.00
e6/l
0.81
56
48
107
194
5.98
57.30
2.3
2.0
5.10
5.08
mmol/24h
0.02
96
172
110
213
5.60
54.90
6.5
5.7
329.39
249.16
iu/ml
0.34
18
31
89
143
6.66
53.71
2.0
2.0
3942.86
2160.00
titre
—
7
7
60
60
10.49
53.48
1.1
1.1
1602.93
1638.92
miu/ml
0.07
60
60
96
181
5.69
49.22
1.4
1.2
696.00
469.33
titre
—
5
15
54
62
9.09
43.42
1.2
1.2
—
—
—
0
0
40
34
12.15
39.58
1.1
1.1
—
—
—
0
0
39
34
11.84
37.97
2.6
3.3
6586.80
976.50
u/ml
—
5
6
816
5872
2.33
37.00
14.2
9.6
4.03
4.06
e9/l
0.14
740
5120
49
61
8.34
36.92
1.3
1.1
1.17
1.12
u/l
0.16
23
33
52
75
7.21
34.56
1.2
1.1
236.95
233.95
mg/l
0.05
43
65
54
82
6.86
34.24
1.2
1.1
45.88
35.00
mg/l
0.82
37
70
51
74
7.16
33.70
1.2
1.1
—
—
—
0
0
203
834
2.74
33.51
4.3
2.7
10.08
10.64
g/l
1.17
185
776
942
7432
2.46
31.17
7.7
4.3
12.08
11.65
mm/h
0.43
904
6973
58
115
5.26
28.02
1.2
1.3
—
—
—
0
0
123
427
3.11
27.39
1.9
2.0
6.11
8.31
iu/ml
0.37
33
99
78
203
4.05
26.95
1.4
1.4
136.63
159.32
au/ml
0.65
16
45
40
60
6.87
25.62
1.6
1.2
0.80
0.52
ratio
1.27
17
38
34
12
29.14
25.48
1.1
1.2
—
—
—
0
0
32
11
29.87
24.17
1.4
2.5
—
—
—
0
0
204
978
2.32
23.72
3.3
2.1
347.70
379.51
nmol/l
1.56
195
912
450
2915
1.89
23.02
5.2
3.8
0.01
0.01
estimate
0.08
183
1020
934
7674
2.14
22.75
13.0
8.2
79.46
78.05
u/l
0.35
900
7306
708
5329
1.85
22.01
5.3
3.7
0.00
0.00
estimate
0.50
203
1081
716
5428
1.84
21.52
5.4
3.8
0.04
0.30
estimate
0.44
190
1036
713
5402
1.84
21.43
5.3
3.8
0.00
4.33
estimate
1.07
204
1105
615
4494
1.79
20.47
18.9
10.9
0.00
0.00
e9/l
0.30
533
3662
329
1987
1.92
20.39
1.3
1.3
23.74
28.91
iu/ml
0.49
80
609
148
657
2.44
20.33
2.3
1.7
1.26
1.48
g/l
0.57
134
608
37
66
5.76
20.01
2.7
2.3
—
—
—
0
0
39
74
5.42
19.76
3.3
2.9
42.33
40.57
%
0.14
17
36
94
338
2.94
19.58
2.8
2.8
—
—
—
0
0
88
306
3.03
19.45
2.1
1.7
0.23
0.24
g/l
0.43
83
293
216
1147
2.09
19.18
4.6
4.5
236.98
245.33
u/l
0.39
204
1090
87
303
3.02
19.18
4.3
3.0
1.55
1.48
mg/l
0.36
82
277
346
2192
1.83
18.10
3.8
2.6
4.39
6.11
e6/l
2.02
328
2005
594
4412
1.71
17.66
6.6
4.9
35.37
35.98
g/l
1.84
564
4148
232
1311
1.96
17.17
9.8
5.4
1.04
1.03
mmol/l
0.41
218
1197
740
5876
1.72
16.86
6.8
5.0
6.84
6.57
mmol/l
2.77
707
5557
113
482
2.49
16.84
3.1
2.1
0.00
0.01
estimate
0.50
26
146
73
249
3.06
16.68
1.4
1.4
646.91
946.66
e6/l
0.16
64
192
72
245
3.07
16.52
1.4
1.4
10.55
52.36
e6/l
0.86
58
183
648
5013
1.67
15.82
11.4
6.9
1.22
1.21
mmol/l
2.53
560
4351
101
422
2.53
15.71
1.2
1.2
0.34
1.17
u/ml
—
5
27
452
3199
1.68
15.47
6.3
3.9
13.71
7.51
mg/mmol
1.28
314
1978
419
2910
1.69
15.38
4.7
3.2
0.01
0.04
estimate
0.44
174
868
475
3413
1.67
15.29
5.0
3.2
7.23
7.77
mmol/l
1.79
404
2938
20
9
22.58
14.24
1.1
1.0
—
—
—
0
0
146
747
2.09
14.09
4.4
3.7
1.23
1.23
mmol/l
0.14
129
645
41
108
3.90
13.96
1.1
1.1
—
—
—
0
0
790
6541
1.66
13.85
6.6
4.5
4822.73
2030.75
e6/l
0.41
11
92
249
1533
1.80
13.83
3.1
2.4
2.28
2.33
g/l
0.67
226
1426
581
4476
1.60
13.59
16.9
13.1
1.20
1.22
inr
0.45
506
3721
581
4481
1.60
13.49
9.6
6.3
1.22
1.21
mmol/l
2.55
544
4151
499
3716
1.60
13.40
5.2
3.8
77.27
114.02
e6/l
0.62
384
2587
669
5351
1.60
13.19
8.7
6.6
10.00
11.47
umol/l
4.54
630
5132
62
221
2.91
13.13
1.3
1.3
282.55
247.11
u/ml
0.44
33
137
261
1657
1.74
12.95
3.1
2.4
12.41
13.36
umol/l
1.10
243
1550
39
107
3.74
12.56
1.3
1.6
49.86
59.74
%
0.57
21
72
495
3727
1.58
12.39
4.1
3.6
51.64
75.02
ng/l
0.45
350
2543
530
4056
1.57
12.34
5.2
3.6
0.02
0.03
estimate
0.25
177
893
227
1406
1.77
12.21
3.3
2.4
22.24
23.03
%
0.32
214
1318
26
53
5.00
12.19
1.3
1.2
—
—
—
0
0
151
832
1.94
11.79
2.4
2.6
72.11
70.68
e9/l
0.21
120
610
436
3218
1.57
11.74
4.5
3.3
61.73
76.20
e6/l
0.22
360
2439
50
169
3.05
11.64
3.3
3.1
3087.00
2030.47
u/ml
—
5
15
582
4589
1.54
11.60
3.0
2.4
76.53
77.05
nmol/l
0.17
533
4182
94
437
2.25
11.51
1.7
1.9
1.58
1.57
g/l
0.03
84
384
147
819
1.91
11.08
2.5
2.8
66.81
66.81
g/l
0.00
136
754
381
2771
1.56
10.73
4.3
3.2
0.20
0.40
e6/l
2.96
304
2007
252
1674
1.65
10.32
4.6
3.3
0.81
0.82
mmol/l
0.46
236
1579
26
64
4.13
9.73
2.9
2.3
747.83
598.62
ml
0.85
18
45
31
87
3.63
9.70
1.9
1.1
123.32
113.16
pmol/l
0.37
31
87
85
409
2.16
9.58
2.4
1.9
1.69
1.53
ug/l
0.06
76
369
338
2458
1.53
9.27
1.5
1.3
2.04
1.76
u/ml
0.13
103
678
1057
9804
1.94
8.94
25.5
15.1
19.98
24.02
mg/l
4.59
929
8029
19
39
4.94
8.85
1.1
1.0
348.17
42.67
ng/l
—
6
6
300
2154
1.53
8.64
1.8
1.5
2.22
2.42
g/l
1.32
206
1349
29
87
3.39
8.24
1.2
1.1
—
—
—
0
0
51
210
2.49
8.24
1.7
1.6
—
—
—
0
0
16
18
9.00
8.05
1.2
1.1
110.50
97.22
%
0.73
16
18
29
89
3.32
7.97
1.2
1.1
—
—
—
0
0
29
89
3.32
7.97
1.2
1.1
—
—
—
0
0
30
95
3.22
7.85
1.3
1.1
—
—
—
0
0
16
19
8.52
7.82
1.1
1.1
—
—
—
0
0
28
86
3.31
7.69
1.2
1.2
—
—
—
0
0
441
3483
1.43
7.66
4.0
3.5
2.35
2.36
mmol/l
0.18
405
3162
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21
53
4.02
7.63
1.0
1.1
—
—
—
0
0
280
2030
1.50
7.57
1.6
1.7
63596924.92
28871203.51
pmol/l
0.34
228
1718
18
41
4.44
7.44
1.2
1.1
—
—
—
0
0
367
2825
1.44
7.25
3.6
3.1
1403.43
1124.39
ng/l
0.63
321
2393
1062
9968
1.83
7.16
26.9
17.6
139.58
139.67
mmol/l
0.57
1047
9776
50
219
2.34
7.10
1.6
1.5
—
—
—
0
0
58
271
2.20
7.08
1.9
1.7
—
—
—
0
0
1063
9986
1.83
7.06
27.2
17.7
3.96
3.96
mmol/l
0.06
1045
9777
339
2605
1.43
6.66
3.1
2.7
355.26
338.64
umol/l
2.01
300
2319
128
796
1.68
6.63
2.3
2.6
65.44
69.60
ml/min/173m2
0.51
63
337
30
106
2.88
6.56
1.2
1.2
—
—
—
0
0
122
754
1.69
6.47
5.5
3.8
86.38
82.96
ng/l
0.19
104
671
30
107
2.85
6.45
1.9
1.7
—
—
—
0
0
390
3086
1.40
6.45
2.9
2.1
140.15
249.30
u/l
2.06
372
2939
58
282
2.11
6.43
1.3
1.3
—
—
—
0
0
28
97
2.93
6.34
1.2
1.2
52.86
51.16
u/l
0.07
22
91
18
35
5.21
6.33
1.4
1.3
—
—
—
0
0
403
3215
1.39
6.32
4.2
2.5
60.80
63.35
u/l
0.22
371
2994
107
644
1.73
6.25
4.9
3.4
5.08
5.15
kpa
0.43
102
622
21
63
3.38
6.02
1.4
1.2
—
—
—
0
0
59
297
2.04
5.99
3.0
3.5
1.24
4.21
ratio
1.27
34
170
194
1366
1.51
5.93
2.2
2.4
89.03
125.20
ug/g
2.19
154
1095
15
26
5.83
5.84
1.0
1.1
—
—
—
0
0
37
155
2.43
5.84
1.2
1.3
—
—
—
0
0
214
1542
1.48
5.84
1.7
1.7
1160.82
1177.94
nmol/l
0.10
165
1151
92
544
1.75
5.73
4.8
3.3
1.39
2.03
mmol/l
0.77
67
405
47
221
2.17
5.70
1.6
1.6
—
—
—
0
0
43
196
2.24
5.62
3.4
2.3
197.41
78.22
ug/min
0.97
26
117
16
42
3.85
5.55
1.2
1.0
—
—
—
0
0
17
47
3.66
5.49
1.1
1.2
—
—
—
0
0
62
329
1.93
5.45
3.6
3.5
39.41
29.55
mg/l
0.82
50
284
62
330
1.93
5.41
3.6
3.5
36.23
64.06
mg/l
0.87
50
286
31
124
2.54
5.40
1.8
1.8
31.23
32.34
pg
0.52
31
124
14
25
5.66
5.38
1.0
1.1
—
—
—
0
0
38
168
2.30
5.35
1.2
1.1
—
0.96
—
0
9
11
14
7.92
5.35
1.4
2.5
—
—
—
0
0
222
1639
1.44
5.31
2.4
1.9
—
—
—
0
0
431
3557
1.34
5.21
4.5
3.3
32.63
32.27
u/l
0.07
400
3370
19
59
3.26
5.18
1.4
1.6
8.71
6.41
u/l
0.27
14
49
1008
9474
1.51
5.07
22.9
14.5
80.94
83.25
ml/min/173m2
2.68
938
8764
13
23
5.70
5.07
1.1
1.0
—
—
—
0
0
11
16
6.93
4.96
1.1
1.0
—
—
—
0
0
19
61
3.15
4.93
14.3
9.1
40.44
42.32
u/ml
—
9
19
13
24
5.47
4.92
1.1
1.0
—
—
—
0
0
856
7833
1.36
4.89
5.0
4.4
14.99
14.71
pmol/l
2.64
791
7242
245
1866
1.40
4.89
1.3
1.3
9.52
11.42
u/ml
0.18
105
706
10
13
7.75
4.85
1.0
1.2
—
—
—
0
0
1088
10429
1.77
4.83
31.3
19.5
80.13
75.52
umol/l
4.33
1081
10314
327
2614
1.35
4.82
2.7
2.2
3.08
2.82
mg/l
0.97
291
2232
8
7
11.50
4.79
1.0
1.1
—
—
—
0
0
59
324
1.87
4.72
1.3
1.2
16.20
15.18
u/ml
—
5
13
57
310
1.88
4.70
1.4
1.2
8.86
8.99
u/ml
0.01
11
44
38
180
2.15
4.58
2.2
1.8
—
—
—
0
0
36
167
2.19
4.56
1.5
1.5
—
—
—
0
0
206
1542
1.41
4.53
2.8
2.1
28.89
29.45
s
0.90
200
1500
50
264
1.93
4.51
1.9
1.6
—
—
—
0
0
38
182
2.12
4.46
2.6
2.6
16.22
16.02
%
0.16
38
177
109
721
1.57
4.44
2.2
1.6
—
—
—
0
0
26
106
2.49
4.40
4.9
3.6
55.35
54.46
%
0.08
26
97
56
310
1.85
4.39
1.3
1.2
5.89
2.36
u/ml
—
10
29
108
715
1.56
4.38
1.4
1.3
145.35
209.64
u/ml
0.42
97
658
17
55
3.12
4.37
1.1
1.0
—
—
—
0
0
42
212
2.02
4.31
1.5
1.5
—
—
—
0
0
56
312
1.84
4.30
1.5
1.3
—
—
—
0
0
62
359
1.77
4.21
2.7
2.0
—
—
—
0
0
9
13
6.97
4.16
1.0
1.1
—
—
—
0
0
556
4857
1.28
4.12
3.6
3.0
131.30
120.26
ug/l
0.54
515
4560
139
985
1.47
4.10
3.7
3.2
—
—
—
0
0
69
416
1.70
4.07
3.5
3.1
24.48
25.37
mmol/l
1.32
62
402
24
98
2.48
4.07
2.1
1.8
—
—
—
0
0
12
26
4.65
4.06
1.1
1.2
—
—
—
0
0
25
105
2.41
4.00
1.2
1.6
—
—
—
0
0
133
942
1.47
3.94
4.7
3.4
1.28
2.03
mmol/l
1.93
112
810
50
278
1.83
3.89
2.0
1.7
—
—
—
0
0
57
331
1.76
3.85
2.5
1.9
—
—
—
0
0
241
1901
1.34
3.79
4.3
3.8
664.65
507.30
ng/l
0.13
177
1440
14
44
3.21
3.78
1.4
1.1
247.93
172.50
iu/ml
0.21
14
44
6
5
12.05
3.76
1.2
1.2
—
—
—
0
0
6
5
12.05
3.76
1.0
1.0
—
—
—
0
0
705
6384
1.27
3.73
3.2
3.1
—
—
—
0
0
105
717
1.51
3.73
4.4
3.0
116.32
201.43
ng/l
3.30
99
663
10
20
5.03
3.69
2.0
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
292
1.78
3.63
2.6
2.8
0.38
0.38
iu/ml
0.01
26
154
38
199
1.94
3.56
2.9
4.0
313.13
1538.94
u/ml
0.50
32
188
7
9
7.82
3.56
1.0
1.3
—
—
—
0
0
980
9286
1.37
3.56
8.4
6.0
40.47
38.62
mmol/mol
7.14
931
8729
43
235
1.86
3.55
2.9
2.7
8.26
7.95
kpa
0.80
43
230
50
287
1.78
3.54
1.5
1.3
—
—
—
0
0
973
9213
1.36
3.52
6.1
5.4
1.93
1.88
mu/l
0.56
914
8565
285
2327
1.30
3.49
2.3
1.7
1.10
1.18
mg/l
0.17
224
1790
1076
10379
1.55
3.44
20.6
11.8
26.63
26.59
u/l
0.03
1062
10113
10
22
4.58
3.43
1.0
1.2
—
—
—
0
0
22
94
2.37
3.42
2.2
1.7
3.03
3.60
mg/l
0.45
22
89
43
239
1.83
3.39
1.6
1.5
—
—
—
0
0
13
42
3.12
3.37
3.2
4.3
—
—
—
0
0
8
14
5.75
3.34
1.0
1.0
—
—
—
0
0
21
89
2.38
3.33
1.7
1.8
—
—
—
0
0
16
59
2.74
3.33
1.4
1.6
—
—
—
0
0
65
410
1.62
3.28
1.6
2.2
3.48
3.65
g/l
0.26
60
382
65
410
1.62
3.28
1.6
2.2
4.29
4.24
g/l
0.18
60
382
65
410
1.62
3.28
1.6
2.2
7.21
7.36
g/l
0.30
60
382
27
130
2.10
3.20
1.9
1.4
—
—
—
0
0
7
11
6.39
3.19
1.0
1.4
—
—
—
0
0
15
55
2.75
3.16
1.5
1.6
—
—
—
0
0
160
1220
1.36
3.13
2.1
1.8
—
—
—
0
0
41
231
1.80
3.11
2.4
2.4
125.00
126.81
g/l
0.18
30
179
26
125
2.10
3.10
1.9
1.4
—
—
—
0
0
26
125
2.10
3.10
1.9
1.4
—
—
—
0
0
27
132
2.07
3.08
1.9
1.4
—
—
—
0
0
22
99
2.25
3.07
1.5
1.2
—
—
—
0
0
485
4272
1.23
3.05
2.5
1.9
1.38
1.36
mmol/l
0.17
402
3652
26
126
2.09
3.04
1.9
1.4
—
—
—
0
0
13
45
2.91
3.03
1.3
2.0
—
—
—
0
0
49
294
1.70
3.01
1.6
1.4
258.46
301.08
ug/g
0.93
33
172
12
37
3.27
2.93
1.9
1.8
41.56
41.52
g/l
0.01
12
37
16
64
2.52
2.88
1.5
1.6
—
—
—
0
0
535
4781
1.22
2.87
3.4
2.7
—
—
estimate
—
0
0
60
385
1.59
2.86
1.5
2.3
2.61
2.96
g/l
1.88
55
357
13
47
2.79
2.82
1.7
1.2
—
—
—
0
0
13
47
2.79
2.82
1.7
1.2
—
—
—
0
0
33
181
1.85
2.76
5.1
2.7
6.98
7.90
pmol/l
0.37
33
181
213
1724
1.29
2.75
3.4
2.9
0.93
0.96
e6/l
0.08
114
891
11
34
3.26
2.73
1.0
1.7
—
—
—
0
0
26
132
1.99
2.72
1.9
1.4
—
—
—
0
0
15
60
2.52
2.71
1.7
1.3
—
—
—
0
0
15
60
2.52
2.71
1.7
1.3
—
—
—
0
0
87
613
1.45
2.70
3.0
3.8
4.48
4.58
pmol/l
0.46
73
542
105
770
1.40
2.63
1.2
1.2
181.02
129.40
u/ml
0.43
36
299
12
41
2.95
2.62
2.8
1.3
193.97
180.97
mmol/24h
0.16
12
41
495
4425
1.21
2.56
2.2
2.1
96.21
96.18
pmol/l
0.00
284
2339
30
164
1.85
2.55
1.3
1.2
1.42
4.06
u/ml
0.95
12
49
54
351
1.56
2.47
6.4
3.8
24.68
25.07
mmol/l
0.40
48
330
35
203
1.75
2.47
1.7
1.5
—
—
—
0
0
81
575
1.44
2.44
12.5
10.3
15.88
16.00
%
0.15
74
553
10
32
3.14
2.44
4.7
2.7
0.61
0.59
mmol/l
—
10
32
24
124
1.96
2.41
2.2
1.8
—
—
—
0
0
44
275
1.62
2.37
1.3
1.3
—
—
—
0
0
14
58
2.43
2.37
1.3
1.1
—
—
—
0
0
25
133
1.90
2.32
1.7
1.7
—
—
—
0
0
150
1189
1.30
2.28
3.3
2.6
6.02
7.86
umol/l
1.16
122
1057
19
92
2.08
2.28
1.5
1.1
74.00
82.50
titre
—
5
12
36
216
1.69
2.27
6.7
1.5
0.88
0.92
nmol/l
0.14
30
183
25
135
1.87
2.23
1.1
1.2
—
—
—
0
0
873
8295
1.22
2.15
29.6
18.8
13.81
13.57
%
5.65
867
8193
327
2851
1.21
2.13
1.9
1.7
19.60
20.49
nmol/l
0.48
280
2437
230
1936
1.23
2.13
1.6
1.6
—
—
—
0
0
18
88
2.06
2.12
1.5
1.4
—
—
—
0
0
28
160
1.77
2.11
1.3
1.2
4.31
6.70
u/ml
0.41
13
66
8
25
3.21
2.09
1.0
1.2
—
—
—
0
0
16
75
2.15
2.09
1.5
1.6
15.32
12.51
umol/l
0.58
16
70
53
360
1.49
2.03
1.9
2.5
0.52
1.15
g/l
0.92
41
321
12
50
2.41
2.03
1.8
1.7
—
—
—
0
0
12
50
2.41
2.03
1.8
1.7
—
—
—
0
0
12
50
2.41
2.03
1.8
1.7
—
—
—
0
0
12
50
2.41
2.03
1.8
1.7
—
—
—
0
0
8
26
3.09
2.01
1.1
1.1
—
—
—
0
0
10
38
2.65
2.00
1.9
1.7
—
—
—
0
0
10
38
2.65
2.00
1.9
1.7
—
—
—
0
0
58
403
1.46
2.00
2.3
2.2
580.12
6182.87
u/l
3.06
18
171
25
141
1.79
1.98
3.3
2.8
11.00
31.39
u/ml
0.35
25
141
16
77
2.09
1.97
1.8
1.7
—
—
—
0
0
1096
10728
1.44
1.94
37.3
23.1
257.80
251.99
e9/l
2.07
1084
10535
10
39
2.58
1.94
1.9
1.7
—
—
—
0
0
1096
10729
1.44
1.93
37.0
23.0
91.28
91.01
fl
1.29
1090
10622
11
45
2.46
1.93
1.7
1.8
60.43
54.98
ug/l
0.11
11
45
54
373
1.47
1.92
1.6
1.7
—
—
—
0
0
1096
10732
1.43
1.90
37.1
23.1
4.46
4.50
e12/l
1.86
1083
10510
1096
10732
1.43
1.90
38.1
23.6
40.15
40.46
%
1.10
1089
10620
63
450
1.42
1.89
6.3
4.8
1.58
1.56
%
0.09
58
424
33
205
1.63
1.87
7.6
6.7
105.21
105.59
mmol/l
0.13
28
184
1096
10734
1.43
1.87
37.2
23.2
6.91
6.70
e9/l
0.66
1083
10507
1096
10734
1.43
1.87
37.4
23.3
134.49
135.58
g/l
1.63
1089
10625
13
59
2.22
1.84
1.2
1.6
—
1224609.80
—
0
5
142
1151
1.27
1.84
11.0
8.3
0.73
1.01
mmol/l
0.37
110
940
44
297
1.50
1.77
1.3
1.3
—
—
—
0
0
7
24
2.93
1.72
2.4
1.7
—
—
—
0
0
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
274
2406
1.18
1.62
5.4
3.9
1.02
1.65
kg/l
0.50
189
1600
5
14
3.58
1.61
1.0
1.1
—
—
—
0
0
30
190
1.59
1.61
3.6
3.2
7.46
7.33
mmol/l
0.10
30
185
134
1098
1.25
1.60
6.8
6.7
—
—
—
0
0
188
1597
1.21
1.60
3.5
3.0
3.06
2.71
e6/l
0.16
90
766
24
144
1.68
1.58
1.1
1.4
—
0.49
nmol/l
—
0
10
12
57
2.12
1.55
1.1
1.3
—
53.33
—
0
6
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
5
15
3.34
1.52
2.0
2.2
—
—
—
0
0
7
27
2.60
1.51
12.3
3.4
10.67
10.43
kpa
—
7
27
7
27
2.60
1.51
12.3
3.4
4.70
4.72
kpa
—
7
27
50
359
1.41
1.51
1.5
2.3
10.63
10.34
g/l
0.19
45
330
94
1175
0.78
1.50
2.0
2.0
3.35
3.48
ratio
0.64
75
934
14
72
1.96
1.49
1.8
1.5
—
—
—
0
0
140
1164
1.23
1.48
11.6
8.3
4.90
5.13
kpa
2.28
130
1115
21
124
1.71
1.48
3.1
1.6
30.76
35.25
ng/l
0.11
21
124
21
125
1.69
1.44
1.2
1.4
—
—
—
0
0
140
1168
1.23
1.44
2.0
2.0
—
—
—
0
0
76
590
1.31
1.42
2.1
1.7
—
—
—
0
0
801
8343
0.87
1.39
28.8
19.6
331.94
332.54
g/l
1.04
796
8300
139
1164
1.22
1.38
11.7
8.3
12.61
12.22
kpa
0.36
129
1118
79
619
1.30
1.38
7.3
6.9
24.36
24.53
mmol/l
0.13
71
591
12
60
2.01
1.38
1.1
1.3
—
481.67
—
0
6
38
264
1.45
1.38
1.6
1.6
14240.40
14534.36
e6/l
0.02
30
191
5
17
2.95
1.36
2.0
2.1
—
—
—
0
0
118
974
1.24
1.35
13.2
9.0
120.22
121.42
g/l
0.28
111
951
14
75
1.88
1.34
1.4
2.2
1.88
1.79
u/field
—
8
42
39
274
1.44
1.34
3.8
3.5
2.91
1.98
index
0.33
23
150
124
1032
1.23
1.32
12.4
8.7
95.71
95.60
%
0.07
116
998
97
786
1.26
1.31
2.7
2.3
7.99
7.37
ug/l
0.12
84
704
144
1218
1.21
1.30
5.5
4.6
32.76
32.19
%
0.29
109
828
18
106
1.71
1.30
2.8
2.5
1.21
1.19
mmol/l
0.39
18
106
18
107
1.69
1.26
2.8
2.4
4.21
4.02
mmol/l
0.76
18
107
18
107
1.69
1.26
2.8
2.4
104.28
105.79
mmol/l
0.65
18
107
978
9518
1.18
1.25
5.8
5.0
6.05
5.88
mmol/l
2.93
919
8812
17
100
1.71
1.24
1.2
1.3
19755.56
129172.32
e6/l
—
9
71
221
1954
1.16
1.21
3.2
2.9
2.45
2.45
mmol/l
0.25
194
1754
33
230
1.45
1.20
3.5
3.1
1.85
1.57
mmol/l
0.34
33
224
11
58
1.91
1.12
4.0
4.1
0.64
0.93
index
0.93
11
58
284
2575
1.14
1.09
5.6
4.0
92.21
91.48
%
0.20
277
2522
5
21
2.39
1.09
1.2
1.2
—
—
—
0
0
277
2509
1.14
1.08
3.2
2.3
—
—
—
0
0
48
365
1.33
1.08
1.2
1.3
—
—
—
0
0
17
105
1.63
1.06
1.2
1.0
—
—
—
0
0
7
33
2.13
1.05
1.0
1.1
—
—
—
0
0
17
106
1.61
1.03
2.6
3.9
—
—
—
0
0
15
91
1.66
1.00
3.7
2.2
—
—
—
0
0
9
48
1.88
1.00
1.0
1.4
—
—
—
0
0
9
48
1.88
1.00
1.0
1.4
—
—
—
0
0
13
212
0.61
0.98
2.2
1.8
—
—
—
0
0
9
50
1.81
0.96
2.6
2.3
—
—
—
0
0
146
1275
1.17
0.96
2.1
2.2
—
—
—
0
0
192
1715
1.14
0.93
1.6
1.5
—
—
—
0
0
64
518
1.25
0.93
1.5
1.4
—
—
—
0
0
20
291
0.68
0.92
1.4
1.1
—
—
—
0
0
23
159
1.46
0.91
1.0
1.1
—
—
—
0
0
20
290
0.68
0.91
1.4
1.1
—
—
—
0
0
15
94
1.60
0.90
2.1
1.2
4.25
0.73
u/ml
—
10
43
310
2858
1.12
0.90
5.3
5.1
2.36
2.15
ug/l
0.31
281
2590
725
6979
1.10
0.90
4.7
3.3
52.99
47.33
u/l
1.04
673
6601
28
202
1.40
0.90
3.8
3.8
26.97
24.55
mg/l
0.10
19
138
61
494
1.25
0.89
4.5
3.3
1.02
1.02
ratio
0.43
56
461
134
1172
1.16
0.88
2.1
1.9
—
—
—
0
0
15
95
1.59
0.87
1.7
1.5
—
—
—
0
0
15
95
1.59
0.87
1.7
1.5
—
—
—
0
0
15
95
1.59
0.87
1.7
1.5
—
—
—
0
0
49
388
1.27
0.86
1.5
1.5
—
—
—
0
0
22
154
1.44
0.83
1.6
1.6
—
—
—
0
0
49
392
1.26
0.81
2.1
1.6
346.30
281.86
mu/l
0.49
44
360
948
9277
1.12
0.79
4.9
4.2
1.32
1.29
mmol/l
0.82
879
8628
34
435
0.77
0.74
1.2
1.2
0.90
0.91
g/l
0.09
34
435
5
25
2.00
0.72
1.0
1.0
18.64
61.27
iu/ml
—
5
25
90
778
1.17
0.71
1.7
1.4
—
—
—
0
0
994
9770
1.13
0.70
6.0
5.0
4.58
4.68
mmol/l
2.14
936
9199
1008
9916
1.13
0.70
6.5
5.6
2.66
2.75
mmol/l
2.72
946
9294
9
58
1.56
0.70
1.7
1.5
124.00
89.52
ng/l
—
9
58
5
27
1.86
0.68
1.4
2.0
11.52
16.29
umol/l
—
5
27
33
418
0.78
0.68
1.1
1.2
1.54
1.55
g/l
0.07
33
418
76
882
0.85
0.67
1.6
1.8
3.39
3.49
mmol/l
0.43
57
636
14
95
1.48
0.64
1.4
1.4
1.86
1.36
nmol/l
1.00
14
85
28
359
0.77
0.64
1.5
1.5
—
—
—
0
0
69
594
1.17
0.60
2.2
2.1
—
—
—
0
0
989
9738
1.11
0.59
5.9
4.9
1.45
1.47
mmol/l
0.48
923
9114
44
529
0.83
0.59
1.5
1.4
—
—
—
0
0
26
330
0.78
0.56
1.4
1.5
—
—
—
0
0
11
73
1.51
0.56
2.5
1.8
—
—
—
0
0
11
160
0.68
0.56
1.1
1.1
2.64
2.09
eliau/ml
—
5
68
10
66
1.52
0.52
2.5
1.9
—
—
—
0
0
56
482
1.17
0.51
1.5
1.8
0.33
0.33
mg/l
0.00
22
230
10
145
0.69
0.50
1.0
1.1
—
—
—
0
0
31
253
1.23
0.48
1.4
1.2
7.33
54.61
u/ml
—
6
23
23
181
1.28
0.48
2.7
3.6
0.84
0.76
nmol/l
0.31
14
149
33
398
0.82
0.48
1.1
1.1
0.57
0.66
ratio
—
7
56
47
401
1.18
0.48
1.8
1.8
9.92
4.63
mg/l
0.53
36
293
93
837
1.12
0.46
2.5
2.4
14.61
13.07
nmol/l
0.87
82
772
10
142
0.70
0.46
1.8
1.5
—
—
—
0
0
112
1023
1.11
0.43
3.3
4.4
46.05
18.61
ug/l
0.67
81
838
13
173
0.75
0.42
1.5
1.6
69.85
50.91
ug/l
0.45
13
173
8
58
1.38
0.41
1.0
1.3
—
—
—
0
0
9
66
1.37
0.38
1.4
1.4
87.44
77.82
umol/l
—
9
66
5
36
1.39
0.38
1.8
1.6
—
—
—
0
0
120
1296
0.92
0.38
1.6
1.8
1.51
1.46
%
0.27
98
1151
241
2293
1.06
0.36
4.4
4.3
21.95
20.96
%
0.47
127
1050
44
388
1.14
0.33
1.4
1.6
19.96
11.80
u/ml
—
7
89
11
83
1.33
0.32
1.2
1.3
—
—
—
0
0
11
84
1.31
0.30
2.4
1.9
15.55
20.48
nmol/l
1.03
11
76
11
84
1.31
0.30
1.2
1.3
—
—
—
0
0
8
63
1.27
0.27
1.1
1.4
207.84
162.34
pmol/l
—
8
63
25
289
0.86
0.26
1.4
1.6
47.11
62.18
ug/l
1.21
19
245
76
707
1.08
0.24
2.4
2.1
—
—
—
0
0
45
493
0.91
0.22
1.4
1.6
945.07
979.34
mu/l
0.10
33
411
0
11
0.00
0.21
0.0
1.4
—
6.12
—
0
11
0
10
0.00
0.21
0.0
1.0
—
0.06
—
0
5
0
10
0.00
0.21
0.0
1.0
—
0.01
—
0
5
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
2.1
—
0.54
—
0
13
104
986
1.06
0.20
3.7
2.4
30.69
38.17
u/l
1.82
87
833
0
14
0.00
0.20
0.0
1.3
—
0.09
—
0
8
6
49
1.23
0.20
7.8
3.2
1.58
1.17
%
—
6
49
35
317
1.11
0.19
1.4
2.2
0.11
0.02
g/l
0.39
28
289
15
127
1.18
0.19
2.5
2.3
4.14
5.81
umol/l
—
8
89
18
207
0.87
0.19
1.1
1.1
0.52
2.19
u/ml
1.79
11
110
6
53
1.13
0.18
1.7
1.2
9.67
9.96
mm/h
—
6
53
58
541
1.08
0.18
1.4
1.4
34.34
27.61
iu/l
0.49
53
468
34
309
1.10
0.18
1.4
2.2
0.00
0.00
g/l
-0.00
26
274
15
171
0.88
0.14
1.1
1.1
0.16
1.53
u/ml
—
7
82
69
655
1.06
0.14
17.1
10.5
1.18
1.29
%
0.88
69
650
32
346
0.92
0.13
2.2
1.9
44.69
39.96
nmol/l
0.55
32
333
26
238
1.09
0.13
1.5
1.6
—
—
—
0
0
25
271
0.92
0.11
1.3
1.5
1.02
1.18
ratio
0.57
14
179
25
271
0.92
0.11
1.3
1.5
1.23
1.22
ratio
0.02
14
179
25
271
0.92
0.11
1.3
1.5
1.07
0.95
ratio
0.34
14
179
68
653
1.04
0.10
17.6
10.7
94.29
93.92
%
0.21
68
648
25
269
0.93
0.10
1.3
1.5
—
—
—
0
0
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
41
389
1.06
0.09
1.3
1.3
167.84
245.32
miu/ml
0.78
14
187
57
547
1.04
0.09
1.1
1.0
—
—
—
0
0
5
60
0.83
0.08
2.2
1.5
—
—
—
0
0
20
188
1.06
0.05
1.4
1.4
—
—
—
0
0
20
188
1.06
0.05
1.4
1.4
—
—
—
0
0
18
172
1.05
0.02
2.0
1.4
0.34
0.32
nmol/l
0.09
13
138
172
1728
0.99
0.01
2.8
3.1
0.74
0.73
ug/l
0.03
113
1072
11
116
0.95
0.00
1.1
1.3
—
—
—
0
0
30
296
1.01
0.00
2.0
2.0
2.56
23.23
iu/l
0.55
11
121
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
6.5
—
—
—
0
0
40
400
1.00
-0.00
2.5
3.3
182.38
3668.43
u/ml
0.81
34
351
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
7.63
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
4.32
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
6
0.00
-0.00
0.0
1.3
—
3497.00
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
10.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_CHORIORETINFLAM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CHORIORETINFLAM | 1.329 [1.13, 1.57] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.086 |
During the follow-up period (1.1.1998 — 31.12.2019), 402 out of 2634 females with H7_CHORIORETINFLAM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CHORIORETINFLAM | 1.492 [1.26, 1.77] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 397 out of 2150 males with H7_CHORIORETINFLAM died.
Mortality risk
Mortality risk for people of age
years, who have H7_CHORIORETINFLAM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.139% | 0.289% |
| 5 | 0.664% | 1.79% |
| 10 | 1.88% | 4.127% |
| 15 | 3.62% | 7.326% |
| 20 | 6.451% | 12.661% |
Relationships between endpoints
↥Index endpoint: H7_CHORIORETINFLAM – Chorioretinal inflammation
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data